Literature DB >> 14705149

Antioxidant effect of acetylsalicylic and salicylic acid in rat brain slices subjected to hypoxia.

J P De La Cruz1, A Guerrero1, J A González-Correa1, M M Arrebola1, F Sánchez de la Cuesta1.   

Abstract

Acetylsalicylic acid (ASA) reduces the incidence of ischemic stroke mainly through its antithrombotic action; however, it also has a direct neuroprotective effect. The present study was designed to evaluate the effect of ASA on oxidative stress and the activity of nitric oxide synthase (NOS) in an in vitro model of hypoxia in rat brain slices. Rat brain slices were perfused with nitrogen (hypoxia) for a maximum of 120 min, after which we measured lipid peroxidation, glutathione levels, glutathione-related enzyme activities, and constitutive nitric oxide synthase (cNOS) and inducible nitric oxide synthase (iNOS) activities. In brain tissue subjected to hypoxia, ASA reduced oxidative stress and iNOS activity (all increased by hypoxia), but only when used at higher concentrations. The effects of salicylic acid (SA) were similar but more intense than were those of ASA. After oral administration, the effect of SA was much greater than that of ASA, and the decrease in cell death with SA was seen much more clearly. In view of the greater effect of SA compared to ASA on changes in oxidative stress parameters in a model of hypoxia, and higher brain concentrations of SA when it is administered alone than when ASA is given (undetectable levels), we conclude that SA plays an important role in the cytoprotective effect in brain tissue after ASA administration. Copyright 2003 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14705149     DOI: 10.1002/jnr.10851

Source DB:  PubMed          Journal:  J Neurosci Res        ISSN: 0360-4012            Impact factor:   4.164


  8 in total

1.  Lack of enantiomeric influence on the brain cytoprotective effect of ibuprofen and flurbiprofen.

Authors:  J A López-Villodres; J P De La Cruz; J Muñoz-Marin; A Guerrero; J J Reyes; J A González-Correa
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2011-06-29       Impact factor: 3.000

2.  Protective effect of triflusal and its main metabolite HTB in an in vitro model of anoxia-reoxygenation in rat brain slices: comparison with acetylsalicylic and salicylic acids.

Authors:  J A González-Correa; M M Arrebola; I M Ureña; D Ruiz-Villafranca; J Muñoz-Marín; A Guerrero; F Sánchez de la Cuesta; J P De La Cruz
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2004-12-16       Impact factor: 3.000

3.  Vernonia Amygdalina Del. stimulated glucose uptake in brain tissues enhances antioxidative activities; and modulates functional chemistry and dysregulated metabolic pathways.

Authors:  Ochuko L Erukainure; Olajumoke A Oyebode; Collins U Ibeji; Neil A Koorbanally; Md Shahidul Islam
Journal:  Metab Brain Dis       Date:  2019-01-03       Impact factor: 3.584

4.  Human ortholog of a plant salicylic acid receptor found in SK-N-SH cell line.

Authors:  Hanna Skubatz; William N Howald
Journal:  Protein J       Date:  2013-12       Impact factor: 2.371

Review 5.  Secondary stroke prevention: inside the vessels and beyond.

Authors:  Matthias W Riepe; Roman Huber
Journal:  CNS Drugs       Date:  2008       Impact factor: 5.749

6.  Assessment of antioxidant effect of 2,5-dihydroxybenzoic acid and vitamin a in brains of rats with induced hyperoxia.

Authors:  David Calderón Guzmán; Francisca Trujillo Jiménez; Ernestina Hernández García; Hugo Juárez Olguín
Journal:  Neurochem Res       Date:  2007-03-31       Impact factor: 4.414

7.  Novel Design of Neuropeptide-Based Drugs with β-Sheet Breaking Potential in Amyloid-Beta Cascade: Molecular and Structural Deciphers.

Authors:  Cosmin Stefan Mocanu; Marius Niculaua; Gheorghita Zbancioc; Violeta Mangalagiu; Gabi Drochioiu
Journal:  Int J Mol Sci       Date:  2022-03-05       Impact factor: 5.923

Review 8.  Oxidative Stress in Preeclampsia and Placental Diseases.

Authors:  Rajaa Aouache; Louise Biquard; Daniel Vaiman; Francisco Miralles
Journal:  Int J Mol Sci       Date:  2018-05-17       Impact factor: 5.923

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.